BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27842554)

  • 1. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients.
    de Laat JM; van der Luijt RB; Pieterman CR; Oostveen MP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
    BMC Med; 2016 Nov; 14(1):182. PubMed ID: 27842554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
    van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
    Giusti F; Cianferotti L; Boaretto F; Cetani F; Cioppi F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Fossi C; Giudici F; Gronchi G; Loli P; Mantero F; Marcocci C; Marini F; Masi L; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Sciortino G; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2017 Nov; 58(2):349-359. PubMed ID: 28132167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. True MEN1 or phenocopy? Evidence for geno-phenotypic correlations in MEN1 syndrome.
    Kövesdi A; Tóth M; Butz H; Szücs N; Sármán B; Pusztai P; Tőke J; Reismann P; Fáklya M; Tóth G; Somogyi A; Borka K; Erdei A; Nagy EV; Deák V; Valkusz Z; Igaz P; Patócs A; Grolmusz VK
    Endocrine; 2019 Aug; 65(2):451-459. PubMed ID: 31044390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
    Romanet P; Mohamed A; Giraud S; Odou MF; North MO; Pertuit M; Pasmant E; Coppin L; Guien C; Calender A; Borson-Chazot F; Béroud C; Goudet P; Barlier A
    J Clin Endocrinol Metab; 2019 Mar; 104(3):753-764. PubMed ID: 30339208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
    Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
    Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma - a case report.
    Radman M; Milicevic T
    BMC Med Genet; 2020 Sep; 21(1):190. PubMed ID: 32993530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
    Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing.
    Ellard S; Hattersley AT; Brewer CM; Vaidya B
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):169-75. PubMed ID: 15670192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.
    Vannucci L; Marini F; Giusti F; Ciuffi S; Tonelli F; Brandi ML
    Endocrine; 2018 Feb; 59(2):438-448. PubMed ID: 28530019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
    Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
    Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN1 and pituitary adenomas.
    Delemer B
    Ann Endocrinol (Paris); 2012 Apr; 73(2):59-61. PubMed ID: 22542456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.
    Horiuchi K; Okamoto T; Iihara M; Tsukada T
    Surg Today; 2013 Aug; 43(8):894-9. PubMed ID: 23052745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).
    Lairmore TC; Piersall LD; DeBenedetti MK; Dilley WG; Mutch MG; Whelan AJ; Zehnbauer B
    Ann Surg; 2004 May; 239(5):637-45; discussion 645-7. PubMed ID: 15082967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of multiple endocrine neoplasia type 1.
    Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
    Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.
    Gatta-Cherifi B; Chabre O; Murat A; Niccoli P; Cardot-Bauters C; Rohmer V; Young J; Delemer B; Du Boullay H; Verger MF; Kuhn JM; Sadoul JL; Ruszniewski P; Beckers A; Monsaingeon M; Baudin E; Goudet P; Tabarin A
    Eur J Endocrinol; 2012 Feb; 166(2):269-79. PubMed ID: 22084155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.